Genitourinary Radiology: Page 10

Italians use AR to bolster prostate cancer surgery
By Abraham Kim
Italian researchers have used augmented reality (AR) technology to overlay dynamic virtual 3D models based on MRI scans directly onto patient anatomy. In a recent article in European Urology, they found their method to be highly effective for prostate cancer surgery.
May 5, 2019
2019 05 03 20 23 2154 Prostate 3 D 400
EAU publishes updated prostate cancer guidelines
By AuntMinnieEurope.com staff writers
The European Association of Urology (EAU) has released new guidelines for the management of prostate cancer.
May 1, 2019
ESTRO: U.K. group finds favor with high-dose brachytherapy
By Abraham Kim
In a study presented on Monday at the European Society for Radiotherapy and Oncology (ESTRO) meeting in Milan, U.K. researchers found that a single session of high-dose-rate brachytherapy safely treated prostate cancer in men, proving especially effective in low-risk cases.
April 29, 2019
2017 10 24 19 20 5633 I Taly Milan Cathedral 400
Can AI help radiologists detect prostate cancer?
By Erik L. Ridley
A team of researchers from the U.S. has developed an artificial intelligence (AI) algorithm that could enable less-experienced radiologists to better detect prostate cancer on multiparametric MRI. The group reported the findings at the recent IEEE International Symposium on Biomedical Imaging in Venice, Italy.
April 17, 2019
2017 06 15 10 31 55 42 Prostate 400
Blue Earth's Axumin agent added to EAU guidelines
By AuntMinnieEurope.com staff writers
Molecular imaging firm Blue Earth Diagnostics said that its Axumin PET imaging agent has been added to the European Association of Urology (EAU) 2019 Clinical Practice Guidelines in Oncology for Prostate Cancer.
April 16, 2019
SPL receives German OK to test Ferrotran MRI contrast
By AuntMinnieEurope.com staff writers
SPL Medical of the Netherlands has received approval in Germany to test its Ferrotran (ferumoxtran-10) MRI contrast agent in a clinical trial.
March 25, 2019
Ga-68 PMSA PET/CT tops for prostate cancer recurrence
By Wayne Forrest
PET/CT with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) should be the choice over whole-body-MRI for detecting prostate cancer recurrence after radical prostatectomy, a German group advocates in a study published by the European Journal of Nuclear Medicine and Molecular Imaging.
March 24, 2019
2019 03 22 22 08 8797 2019 03 25 Ga 68 Psma Petct Prostate Cancer Sawicki 20190322222738
Standardized accreditation is key for prostate MRI
By Edna Astbury-Ward, PhD
Quality in imaging is never guaranteed -- that is why working toward European-wide accreditation for prostate MRI is the way forward, expert speakers explained at this morning's ECR Master Class. Benchmarking quality in acquisition and reporting must be set within clear clinical pathways, and it is a vital part of the accreditation process.
March 2, 2019
2019 03 02 22 06 4881 2019 03 03 Prostate Mri Thumb
Ga-68 PSMA-11 PET/MRI improves prostate cancer detection
By Wayne Forrest
VIENNA - PET/MRI with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) could become a valuable tool in image-guided biopsy and for detecting significant prostate cancer, researchers reported on Wednesday at ECR 2019.
February 28, 2019
2019 02 28 22 32 4413 Pet Mri Biopsy Guidance 400 Thumb
Prostatic artery embolization gains clinical momentum
By Dr. Jamal Al Deen Alkoteesh
Prostate artery embolization has emerged as a highly promising interventional radiology procedure for lower urinary tract symptoms secondary to benign prostatic hypertrophy, Dr. Jamal Al Deen Alkoteesh told Arab Health delegates on the final day of the Total Radiology conference in Dubai, United Arab Emirates.
January 31, 2019
2019 02 01 00 29 7654 2019 02 01 Pae Alkoteesh 400
FDG-PET/CT improves bladder cancer staging
By Wayne Forrest
Combining metabolic and morphologic data from FDG-PET/CT scans can significantly improve the detection of lymph node metastasis in patients with muscle-invasive bladder cancer before their surgery, according to a French study published online on 21 January in European Radiology.
January 30, 2019
2017 10 26 18 32 2756 Cancer Cell Yellow 400
Curium, Progenics partner on PET agent in Europe
By AuntMinnieEurope.com staff writers
Global nuclear medicine firm Curium has joined Progenics Pharmaceuticals in an exclusive agreement to develop and commercialize Progenics' prostate-specific membrane antigen-targeted small molecule PET/CT imaging agent in Europe.
January 2, 2019
Previous Page
Page 10 of 22
Next Page